Timothy Kamp

Dr. Kamp’s lab focuses on embryonic stem cells (ESCs) and their applications to cardiovascular research and potentially cardioregenerative medicine. Their initial studies have provided proof of principal evidence that mouse ESCs can induce regeneration in infarcted mouse heart. Ongoing research focuses on identifying optimal cellular populations derived from ESCs for cardiac therapy, determining the best delivery strategies, and overcoming challenges related to immune rejection of allogeneic cells.